Helen Gall
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 4
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
-
- Cancer therapeutics and mechanisms 4
- Biochemical and Molecular Research 2
- Co-authors
- Herbert M. Pinedo (6 shared papers)Rik J. Scheper (4 shared papers)Jan B. Vermorken (3 shared papers)Janet H. Ransom (1 shared paper)Michael G. Hanna (1 shared paper)A.M.E. Claessen (1 shared paper)Harm van Tinteren (1 shared paper)Elisabeth Bloemena (1 shared paper)
- Journals
- Cancer Nursing (2 papers)Clinical Cancer Research (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Helen Gall
16 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Oncology 872
- Immunology 643
- Chemical Health and Safety 17
- Hepatology 63
- Pulmonary and Respiratory Medicine 240
Countries citing papers authored by Helen Gall
This map shows the geographic impact of Helen Gall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Gall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Gall more than expected).
Fields of papers citing papers by Helen Gall
This network shows the impact of papers produced by Helen Gall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Gall. The network helps show where Helen Gall may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Gall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 379 | |
| 2 | 2012 | 290 | |
| 3 | 2000 | 132 | |
| 4 | 2014 | 91 | |
| 5 | 2012 | 78 | |
| 6 | Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study. | 2002 | 52 |
| 7 | 2006 | 45 | |
| 8 | 1990 | 36 | |
| 9 | 1994 | 30 | |
| 10 | 1996 | 25 | |
| 11 | 2007 | 21 | |
| 12 | 1996 | 20 | |
| 13 | 2006 | 19 | |
| 14 | 1996 | 13 | |
| 15 | 1991 | 5 | |
| 16 | 2013 | 5 |
About Helen Gall
Helen Gall is a scholar working on Oncology, Molecular Biology, Hematology, Immunology and Pathology and Forensic Medicine, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Multiple Myeloma Research and Treatments (3 papers), Prostate Cancer Treatment and Research (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Oncology (872 citations), Immunology (643 citations), Chemical Health and Safety (17 citations), Hepatology (63 citations) and Pulmonary and Respiratory Medicine (240 citations). Helen Gall has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Herbert M. Pinedo, Rik J. Scheper, Jan B. Vermorken, Janet H. Ransom, Michael G. Hanna, A.M.E. Claessen, Harm van Tinteren, Elisabeth Bloemena, Chris J.L.M. Meijer and Sybren L. Meijer. Their work appears in journals such as Cancer Nursing, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.